FUJISAWA, Japan--(BUSINESS WIRE)--SynCrest Inc., a peptide and nucleotide CRDMO (Contract Research, Development and Manufacturing Organization) joint venture between Otsuka Chemical Co., Ltd. and ...

GenScript can synthesize numerous difficult neoantigen peptides and offer specialized optimization tools for specific downstream applications. They have the technical capability and experience to ...

Chemical synthesis and peptide ligation techniques have revolutionised the field of protein engineering by enabling the precise construction of peptides and proteins with tailored modifications. These ...

In May, TheraCode acquired JPT Peptide Technologies, a wholly owned subsidiary of Jerini. JPT offers peptide-based products and services for vaccine development, immune monitoring, and peptide ...

The two companies enter into a multi-year strategic agreement to accelerate drug development timelines, strengthen U.S. manufacturing capabilities and help bring lifesaving medicines to patients ...

The Peptide-ExplorerLT ™ is designed for scientists who need to optimize and explore linear peptide synthesis. The product is a high-spec flow chemistry system that uses continuous flow. The product ...

GenScript's new life-science building in Zhenjiang, Jiangsu, China spans 91,310 sq. ft. and is ISO 9001 certified; highly automated clean-room facilities offer fast-turnaround, high-purity ...

What is it? As the name suggests, nonribosomal peptide synthesis (NRPS) generates polypeptides sans ribosome. The resultant peptides, generally short oligomers of two to perhaps 48 residues, are not ...

Ottawa, Dec. 16, 2025 (GLOBE NEWSWIRE) -- The global chemical synthesis peptide drugs market size is calculated at USD 2.74 billion in 2025 and is expected to reach around USD 4.82 billion by 2034, ...

Therapeutic peptides constitute an unusual drug category. Although most therapeutic peptides are synthetic, their molecular weights are well above those of small-molecule drugs, but well below those ...